Physician profile
Jonelon G Tsang
NPI 1245499045
$4,104.90
in general payments reported to CMS, 2019-2025
31 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $389 · 2021: $839 · 2022: $1,115 · 2023: $658 · 2024: $314 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Education: $25.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.70 |
| Education | $25.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,195.23 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $663.94 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Spr Therapeutics, INC | $266.70 | 2022-2023 | Sprint Pns System |
| Abbvie INC. | $238.35 | 2022-2025 | Botox, Qulipta |
| Saluda Medical Americas, INC. | $161.52 | 2023-2024 | Evoke Scs, Evoke |
| Nalu Medical, INC. | $143.45 | 2021-2024 | Nalu Neurostimulation System |
| Nevro Corp. | $131.38 | 2019-2022 | |
| Painteq LLC | $122.45 | 2021-2023 | Painteq |
| Electronic Waveform Lab, INC. | $110.00 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $106.12 | 2019-2021 | |
| Fidia Pharma USA INC. | $100.67 | 2022-2023 | Triluron, Hymovis |
| Medtronic, INC. | $97.20 | 2022-2025 | Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Scilex Pharmaceuticals INC. | $92.70 | 2019-2024 | Ztlido |
| Si-Bone, INC. | $92.57 | 2020-2025 | |
| Grt US Holding, INC. | $71.04 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $64.66 | 2019-2023 | |
| Merz Pharmaceuticals, LLC | $57.01 | 2023 | Xeomin |
| Biohaven Pharmaceutical Holding Company LTD. | $54.70 | 2022 | |
| Allergan, INC. | $48.72 | 2022 | |
| Bioventus LLC | $47.95 | 2022 | |
| Biotronik Nro, INC. | $36.67 | 2024 | Prospera |
| Pacira Pharmaceuticals Incorporated | $32.57 | 2024 | Iovera, Exparel |
| Averitas Pharma INC. | $29.55 | 2023 | Qutenza |
| Masimo Corporation | $22.28 | 2024 | Patient Safetynet System |
| Almatica Pharma LLC | $21.17 | 2022 | |
| Lilly USA, LLC | $20.24 | 2019 | |
| Hikma Pharmaceuticals USA | $16.65 | 2022 | |
| International Rehabilitative Sciences, INC | $16.55 | 2024 | Rs 4i Plus Sequential Stimulator |
| Biohaven Pharmaceuticals, INC. | $16.40 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.31 | 2021 | |
| Medtronic Vascular, INC. | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonelon Tsang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.